Diagnostic for All (DFA), a startup from Harvard University that I wrote about recently, won the MIT $100K Entrepreneurship Competition last night. DFA, which aims to develop cheap paper diagnostic tools for impoverished countries, differed from most of the competition because it is a not-for-profit. The coinventors of the paper test, George Whitesides and Hayat Sindi, say that it could be used to diagnose, for example, drug-induced liver damage, a major problem that often goes undetected in the developing world. Apparently, their business plan convinced the judges that it is a worthwhile, substantive venture.
The $10,000 Audience Prize went to Covalent Solar, a team that is working on more-efficient thin-film concentrator photovoltaic modules.
This artist is dominating AI-generated art. And he’s not happy about it.
Greg Rutkowski is a more popular prompt than Picasso.
VR is as good as psychedelics at helping people reach transcendence
On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.
This nanoparticle could be the key to a universal covid vaccine
Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.
How do strong muscles keep your brain healthy?
There’s a robust molecular language being spoken between your muscles and your brain.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.